2017 American Transplant Congress
A Nationwide Global Strategy for Kidney Transplantation with Controlled Cardiac Death Donor (cDCD) Has Improved Global Results. Spanish Multicentre SENTRA-GEODAS Group.
Background: Controlled donation after cardiac death (cDCD) programs are running in US for years and some European countries has recently started on it. National transplant…2017 American Transplant Congress
Patient-Reported Barriers to the Pre-Kidney Transplant Evaluation in an At-Risk Population in the United States.
Background: Despite our knowledge of barriers to the early stages of the transplant process, we have limited insight into patient reported barriers to the pre-kidney…2017 American Transplant Congress
Can We Successfully Overcome Obesity as a Barrier for Kidney Transplantation?
Obesity is a significant barrier for kidney transplantation (KT) with higher rates of denial for listing and longer listing to transplantation interval. We examined the…2017 American Transplant Congress
Impact of Pancreas Transplant Failure in Quality of Life in Simultaneous Kidney Pancreas Transplantation.
BackgroundBoth kidney and pancreas transplantation have been shown to be associated with improved quality of life (QoL). In fact, one of the most important outcomes…2017 American Transplant Congress
Benefits of Multimodal Enhanced Recovery Pathway in Patients Undergoing Kidney Transplantation.
Background: Use of Enhanced Recovery After Surgery (ERAS) pathways have been shown to improve patient recovery in several surgical specialties; however, its' effectiveness in kidney…2017 American Transplant Congress
Lymphoproliferative Disorders After Renal Transplantation Along Two Decades: A Large Longitudinal Study.
In a longuitudinal study,we evaluated the cumulative incidence of Posttransplant limphoproliferative disorders(PTLD),its relationship with Epstein Barr Virus (EBV),classical risk factors and outcome in 21546 single…2017 American Transplant Congress
Protective Effect of New Delivery System of Nitric Oxide Releasing Nanofiber in Rat Model of Renal Ischemia-Reperfusion Injury.
Objective: Renal ischemia-reperfusion injury (IRI) is very important in various clinical setting including kidney transplantation. Nitric oxide (NO) is well known for having various protective…2017 American Transplant Congress
Alemtuzumab Induction and Belatacept Maintenance in Marginal Pathology Renal Allografts.
University of Maryland, Baltimore
Background: The potential for improved outcomes with CNI avoidance may be important for kidneys with an increased likelihood of impaired graft function. We performed a…2017 American Transplant Congress
Clinical Outcomes of Simplified Once-Daily Immunosuppressive Regimen for Stable Kidney Recipients.
Aims. Many immunosuppressive drugs are prescribed as twice-daily dosing. Simplified once-daily dosing of the entire drug regimen can improve treatment satisfaction for patients. We examined…2017 American Transplant Congress
The Impact of Early Clinical and Subclinical T Cell Rejection After Kidney Transplantation.
Medicine and Surgery, University of Pittsburgh, Pittsburgh, PA
Purpose: To evaluate the impact of early Clinical(C-TCMR) and Sub-Clinical(SC-TCMR) T Cell Mediated Rejection on short-term allograft histology and function.Methods: We examined adult kidney alone…
- « Previous Page
- 1
- …
- 388
- 389
- 390
- 391
- 392
- …
- 531
- Next Page »